ProShare Advisors’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $224K | Buy |
23,490
+294
| +1% | +$2.8K | ﹤0.01% | 1651 |
|
|
2025
Q1 | $243K | Sell |
23,196
-4,848
| -17% | -$50.7K | ﹤0.01% | 1558 |
|
|
2024
Q4 | $661K | Buy |
28,044
+6,862
| +32% | +$162K | ﹤0.01% | 1113 |
|
|
2024
Q3 | $761K | Buy |
21,182
+6,012
| +40% | +$216K | ﹤0.01% | 898 |
|
|
2024
Q2 | $535K | Sell |
15,170
-1,137
| -7% | -$40.1K | ﹤0.01% | 940 |
|
|
2024
Q1 | $463K | Buy |
16,307
+5,028
| +45% | +$143K | ﹤0.01% | 1137 |
|
|
2023
Q4 | $150K | Buy |
+11,279
| New | +$150K | ﹤0.01% | 1708 |
|
|
2022
Q2 | – | Sell |
-10,966
| Closed | -$105K | – | 1886 |
|
|
2022
Q1 | $105K | Sell |
10,966
-2,853
| -21% | -$27.3K | ﹤0.01% | 2019 |
|
|
2021
Q4 | $163K | Buy |
+13,819
| New | +$163K | ﹤0.01% | 2097 |
|